Patient-specific genomics and cross-species functional analysis implicate LRP2 in hypoplastic left heart syndrome

Abstract

Congenital heart diseases (CHDs), including hypoplastic left heart syndrome (HLHS), are genetically complex and poorly understood. Here, a multi-disciplinary platform was established to functionally evaluate novel CHD gene candidates, based on whole genome and iPSC RNA sequencing of a HLHS family-trio. Filtering for rare variants and altered expression in proband iPSCs prioritized 10 candidates. siRNA/RNAi-mediated knockdown in generic human iPSC-derived cardiomyocytes (hiPSC-CM) and in developing Drosophila and zebrafish hearts revealed that LDL receptor-related protein LRP2 is required for cardiomyocyte proliferation and differentiation. Consistent with hypoplastic heart defects, compared to patents the proband's iPSC-CMs exhibited reduced proliferation. Interestingly, rare, predicted-damaging LRP2 variants were enriched in a HLHS cohort; however, understanding their contribution to HLHS requires further investigation. Collectively, we have established a multi-species high-throughput platform to rapidly evaluate candidate genes and their interactions during heart development, which are crucial first steps towards deciphering oligogenic underpinnings of CHDs, including maladaptive left hearts.

Data availability

Sequencing data are deposited in the NCBI Sequence Read Archive (SRA) database with accession numbers: SRS1417684 (proband iPSCs), SRS1417685 (paternal iPSCs), SRS1417686 (maternal iPSCs), SRS1417695 (proband d25 differentiated cells), SRS1417696 (paternal d25 differentiated cells), SRS1417714 (maternal d25 differentiated cells)

The following previously published data sets were used

Article and author information

Author details

  1. Jeanne L Theis

    Cardiovascular Genetics Research Laboratory, Mayo Clinic, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Georg Vogler

    Development, Aging and Regeneration, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8303-3531
  3. Maria A Missinato

    Development, Aging and Regeneration, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9055-758X
  4. Xing Li

    Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Tanja Nielsen

    Development, Aging and Regeneration, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Xin-Xin I Zeng

    Development, Aging and Regeneration, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2707-7759
  7. Almudena Martinez-Fernandez

    Department of Cardiovascular Medicine, Mayo Clinic, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Stanley M Walls

    Development, Aging and Regeneration, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  9. Anaïs Kervadec

    Development, Aging and Regeneration, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. James N Kezos

    Development, Aging and Regeneration, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Katja Birker

    Development, Aging and Regeneration, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Jared M Evans

    Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Megan M O'Byrne

    Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Zachary C Fogarty

    Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5588-3216
  15. André Terzic

    Department of Cardiovascular Medicine, Mayo Clinic, Rochester, United States
    Competing interests
    The authors declare that no competing interests exist.
  16. Paul Grossfeld

    Rady's Hospital, University of California San Diego, San Diego, United States
    Competing interests
    The authors declare that no competing interests exist.
  17. Karen Ocorr

    Development, Aging and Regeneration, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  18. Timothy J Nelson

    Department of Internal Medicine, Mayo Clinic, Rochester, United States
    For correspondence
    nelson.timothy@mayo.edu
    Competing interests
    The authors declare that no competing interests exist.
  19. Timothy M Olson

    Department of Cardiovascular Medicine, Mayo Clinic, Rochester, United States
    For correspondence
    olson.timothy@mayo.edu
    Competing interests
    The authors declare that no competing interests exist.
  20. Alexandre R Colas

    Development, Aging and Regeneration, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States
    Competing interests
    The authors declare that no competing interests exist.
  21. Rolf Bodmer

    Development, Aging, and Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, United States
    For correspondence
    rolf@sbpdiscovery.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9087-1210

Funding

Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome, Mayo Clinic Foundation, Rochester, MN (SAN-233970)

  • Alexandre R Colas
  • Rolf Bodmer

National Institutes of Health (HL054732)

  • Rolf Bodmer

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Antje Ebert

Ethics

Animal experimentation: SBP has retained the services of a veterinarian who is a diplomat of the American College of Laboratory Animal Medicine. Close contact with Animal Facility personnel is maintained through telephone calls and on-campus visits once a week. This person is a member of the Institute's Animal Care and Use Committee (IACUC)and attends monthly meetings. This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of the animals were handled according to the Institute's Animal Care and Use Program, which is accredited by AAALAC International, and a Multiple Project Assurance A3053-1 is on file in the OLAW, DHHS. The protocol was approved by SBP IACUC (Permit Number: 19-087). Animals are euthanized after filming hearts by an overdose of anesthetic (3-aminobenzoic acid ethyl ester (MS-222) at 250-300 mg/L.

Human subjects: Written informed consent was obtained for the index family and an HLHS cohort, under a research protocol approved by the Mayo Clinic Institutional Review Board (11-000114 "Genetic Investigations in Hypoplastic Left Heart Syndrome").

Version history

  1. Received: June 1, 2020
  2. Accepted: September 29, 2020
  3. Accepted Manuscript published: October 2, 2020 (version 1)
  4. Version of Record published: October 22, 2020 (version 2)
  5. Version of Record updated: November 23, 2020 (version 3)

Copyright

© 2020, Theis et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,284
    views
  • 286
    downloads
  • 28
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jeanne L Theis
  2. Georg Vogler
  3. Maria A Missinato
  4. Xing Li
  5. Tanja Nielsen
  6. Xin-Xin I Zeng
  7. Almudena Martinez-Fernandez
  8. Stanley M Walls
  9. Anaïs Kervadec
  10. James N Kezos
  11. Katja Birker
  12. Jared M Evans
  13. Megan M O'Byrne
  14. Zachary C Fogarty
  15. André Terzic
  16. Paul Grossfeld
  17. Karen Ocorr
  18. Timothy J Nelson
  19. Timothy M Olson
  20. Alexandre R Colas
  21. Rolf Bodmer
(2020)
Patient-specific genomics and cross-species functional analysis implicate LRP2 in hypoplastic left heart syndrome
eLife 9:e59554.
https://doi.org/10.7554/eLife.59554

Share this article

https://doi.org/10.7554/eLife.59554

Further reading

    1. Genetics and Genomics
    Samuel Pattillo Smith, Gregory Darnell ... Lorin Crawford
    Research Article

    LD score regression (LDSC) is a method to estimate narrow-sense heritability from genome-wide association study (GWAS) summary statistics alone, making it a fast and popular approach. In this work, we present interaction-LD score (i-LDSC) regression: an extension of the original LDSC framework that accounts for interactions between genetic variants. By studying a wide range of generative models in simulations, and by re-analyzing 25 well-studied quantitative phenotypes from 349,468 individuals in the UK Biobank and up to 159,095 individuals in BioBank Japan, we show that the inclusion of a cis-interaction score (i.e. interactions between a focal variant and proximal variants) recovers genetic variance that is not captured by LDSC. For each of the 25 traits analyzed in the UK Biobank and BioBank Japan, i-LDSC detects additional variation contributed by genetic interactions. The i-LDSC software and its application to these biobanks represent a step towards resolving further genetic contributions of sources of non-additive genetic effects to complex trait variation.

    1. Evolutionary Biology
    2. Genetics and Genomics
    Yannick Schäfer, Katja Palitzsch ... Jaanus Suurväli
    Research Article Updated

    Copy number variation in large gene families is well characterized for plant resistance genes, but similar studies are rare in animals. The zebrafish (Danio rerio) has hundreds of NLR immune genes, making this species ideal for studying this phenomenon. By sequencing 93 zebrafish from multiple wild and laboratory populations, we identified a total of 1513 NLRs, many more than the previously known 400. Approximately half of those are present in all wild populations, but only 4% were found in 80% or more of the individual fish. Wild fish have up to two times as many NLRs per individual and up to four times as many NLRs per population than laboratory strains. In contrast to the massive variability of gene copies, nucleotide diversity in zebrafish NLR genes is very low: around half of the copies are monomorphic and the remaining ones have very few polymorphisms, likely a signature of purifying selection.